Adrian Funke

Title: Adrian Funke: Innovator in Pharmaceutical Dosage Forms

Introduction

Adrian Funke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of four patents to his name, Funke's work focuses on improving the efficacy and delivery of medications.

Latest Patents

One of Funke's latest patents is titled "Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic." This invention relates to a pharmaceutical dosage form that combines nifedipine or nisoldipine with an angiotensin II antagonist and/or a diuretic. The unique aspect of this formulation is that it allows for controlled release of nifedipine or nisoldipine while enabling rapid release of the other active ingredients. This innovation aims to enhance the treatment of various disorders.

Another significant patent by Funke is the "Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil." This invention outlines the manufacturing processes for creating a dosage form that includes nifedipine and candesartan cilexetil, with an emphasis on controlled and immediate release of the active ingredients. These advancements are crucial for improving patient outcomes in medication management.

Career Highlights

Adrian Funke has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery.

Collaborations

Throughout his career, Funke has collaborated with notable colleagues such as Torsten Wagner and Ralph Lipp. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Adrian Funke's contributions to pharmaceutical innovations demonstrate his commitment to enhancing medication delivery systems. His patents reflect a deep understanding of drug interactions and patient needs, positioning him as a key figure in the field of pharmaceuticals.